Ludwig Isell Lind af Hageby, Senior Associate/Member of the Swedish Bar Association

Profile

I assist both Swedish and international companies with advice on mergers and acquisitions (M&A), equity capital markets and various types of corporate law matters.

In my daily work, I assist clients with advice in connection with, in particular, M&A transactions, IPOs, fundraisings, general meetings and various types of commercial agreements. I also assist Swedish and international clients with advice regarding general corporate law matters and matters relating to compliance with capital market regulations. Further, I have experience of venture capital transactions and advice regarding the creation and implementation of incentive programs in private and public companies.

Språk: English, Swedish, Swedish

Karriär

2016-

Setterwalls

2016

Lund University, LL.M.

Case

Setterwalls advises Cantargia in connection with a capital raise of approximately SEK 124 million and entering into a loan agreement

Setterwalls has advised Ascelia Pharma in connection with a private placement

Setterwalls has advised Intellego Technologies in connection with SEK 210 million private placement

Setterwalls advises Alligator Bioscience in connection with a capital raise of approximately SEK 120 million and renegotiation of loan

Setterwalls advises Immunovia in connection with a rights issue of approximately SEK 100 million

Setterwalls advises Guard Therapeutics AB in connection with a rights issue

Setterwalls advises Alligator Bioscience in connection with a rights issue of approximately SEK 280 million

Setterwalls has advised OptiCept Technologies in connection with a rights issue

Setterwalls advised Ascelia Pharma in connection with a fully subscribed rights issue of units

Setterwalls advised Immunovia in connection with a rights issue of units

Setterwalls advises Alligator Bioscience in connection with rights issue of approximately SEK 150 million

Setterwalls has assisted SynAct Pharma in connection with the acquisition of TXP Pharma and private placement

Setterwalls has advised Guard Therapeutics in connection with private placement of approximately SEK 120 million

Setterwalls has advised InCoax Networks in connection with rights issue and over-allotment

Setterwalls has advised SynAct Pharma AB in connection with listing on Nasdaq Stockholm

Setterwalls has advised Respiratorius and Arcede Pharma in connection with a rights issue and Lex Asea distribution of shares

Setterwalls has advised inriver AB in connection with a major growth investment from Thomas H. Lee Partners (THL)

Setterwalls has advised SynAct Pharma AB in connection with a fully guaranteed rights issue of approximately SEK 150 million

Setterwalls has advised Alligator Bioscience in connection with rights issue of approximately SEK 257 million

Setterwalls has advised Guard Therapeutics in connection with private placement and rights issue of in total approximately SEK 182 million

Setterwalls has advised Aptahem in connection with rights issue

Setterwalls has advised Amniotics AB (publ) in connection with listing on Nasdaq First North Growth Market

Setterwalls advises Qlife Holding in connection with SEK 90 million private placement

Setterwalls has advised WntResearch in connection with rights issue

Setterwalls advises Ascelia Pharma in connection with SEK 200 million private placement

Setterwalls has advised SynAct Pharma in connection with SEK 80 million private placement

Setterwalls has advised Alligator Bioscience in connection with over-subscribed rights issue

Setterwalls has assisted Polygiene in connection with private placement and the acquisition of Addmaster

Setterwalls has advised Curando Nordic AB in connection with a rights issue

Setterwalls has advised Idogen in connection with rights issue of units

Setterwalls advises inRiver in connection with private placement of approximately SEK 285 million

Setterwalls has advised Aptahem in connection with over-subscribed rights issue

Setterwalls has advised Guard Therapeutics in connection with rights issue and over-allotment

Setterwalls has advised InCoax Networks AB in connection with an oversubscribed rights issue

Setterwalls has advised Advenica in connection with a substantially oversubscribed rights issue

Setterwalls has advised Safeture in connection with oversubscribed rights issue

Setterwalls has advised BONESUPPORT in connection with SEK 378 million private placement

Setterwalls has advised WntResearch in connection with oversubscribed rights issue

Setterwalls advises Qlife Holding AB in connection with the listing on Nasdaq First North Growth Market

Setterwalls has assisted BrainLit in connection with private placement

Setterwalls advises Better Collective in connection with SEK 312 million private placement

Setterwalls has advised RhoVac in connection with a rights issue of approximately SEK 180.9 million

Setterwalls has assisted Ascelia Pharma in this year’s first listing at Nasdaq Stockholm

Setterwalls has advised EQL Pharma in connection with oversubscribed rights issue

Setterwalls advises DevPort AB (publ) in connection with the acquisition of the technology consultant ADIGA AB

Setterwalls advises Better Collective in connection with listing on Nasdaq Stockholm

Setterwalls has advised Arise in a rights issue of convertible bonds amounting to SEK 245 million

Setterwalls advises Svedbergs in connection with an acquisition

Arise AB has sold the wind farm Bohult to a fund managed by Allianz Global Investors